C5L2, a nonsignaling C5A binding protein

被引:225
作者
Okinaga, S
Slattery, D
Humbles, A
Zsengeller, Z
Morteau, O
Kinrade, MB
Brodbeck, RM
Krause, JE
Choe, HR
Gerard, NP
Gerard, C
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[2] Neurogen Corp, Branford, CT 06505 USA
关键词
D O I
10.1021/bi034489v
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
C5a anaphylatoxin, a potent inflammatory mediator, is known to act through a specific G protein coupled receptor. However, some of the complex effects of C5a in vivo may not be explained solely by the deletion of the known receptor. Here, we show that an orphan receptor, identified as C5L2, is a high affinity C5a binding protein. Unlike the previously described C5aR, C5L2 is obligately uncoupled from heterotrimeric G proteins, in part by virtue of an amino acid alteration in the so-called DRY sequence at the end of the third transmembrane segement. Both human and murine C5L2 bear a leucine for arginine replacement at this site. C5L2, when transfected into several cell types, is weakly phosphorylated in transfected cells following binding of C5a but does not induce significant activation of MAP kinases, mediate calcium flux, or stimulate chemotaxis. Bone marrow cells from wild type respond robustly to C5a with induction and suppression of a number of inflammation related genes. In contrast, C5a receptor deficient mice, which bear C5L2 alone, do not respond to C5a with changes in gene transcription by microarray analyses. Biophysical properties of the C5L2, including slow ligand on and off rates, absence of internalization, and relatively high affinity for the C5a des Arg metabolite, suggest that this receptor may serve to modulate C5a biological functions in vivo. Finally, in contrast to previous reports, we find absolutely no interaction of C5L2 with other anaphylatoxins C3a and C4a.
引用
收藏
页码:9406 / 9415
页数:10
相关论文
共 41 条
[1]  
AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139
[2]   Cutting edge:: Guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease:: Evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma [J].
Bautsch, W ;
Hoymann, HG ;
Zhang, QW ;
Meier-Wiedenbach, I ;
Raschke, U ;
Ames, RS ;
Sohns, B ;
Flemme, N ;
zu Vilsendorf, AM ;
Grove, M ;
Klos, A ;
Köhl, J .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5401-5405
[3]   Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury [J].
Bhatia, M ;
Saluja, AK ;
Singh, VP ;
Frossard, JL ;
Lee, HS ;
Bhagat, L ;
Gerard, C ;
Steer, ML .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 280 (05) :G974-G978
[4]   EXPRESSION CLONING OF A RECEPTOR FOR C5A ANAPHYLATOXIN ON DIFFERENTIATED HL-60 CELLS [J].
BOULAY, F ;
MERY, L ;
TARDIF, M ;
BROUCHON, L ;
VIGNAIS, P .
BIOCHEMISTRY, 1991, 30 (12) :2993-2999
[5]   The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg74 [J].
Cain, SA ;
Monk, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) :7165-7169
[6]   Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis [J].
Campbell, W ;
Okada, N ;
Okada, H .
IMMUNOLOGICAL REVIEWS, 2001, 180 :162-167
[7]  
DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446
[8]   Cutting edge: The absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy [J].
Drouin, SM ;
Corry, DB ;
Kildsgaard, J ;
Wetsel, RA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4141-4145
[9]   Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma [J].
Drouin, SM ;
Kildsgaard, J ;
Haviland, J ;
Zabner, J ;
Jia, HP ;
McCray, PB ;
Tack, BF ;
Wetsel, RA .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :2025-2032
[10]   Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils [J].
Eglite, S ;
Plüss, K ;
Dahinden, CA .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :2183-2189